Why diversity in clinical trials is matter of life or death
Clip: 10/30/2019 | 9m 10s | Video has closed captioning.
U.S. racial and ethnic diversity is ever increasing, but the medical representation of minority groups is not. A recent review of government-funded cancer research studies found that participants were disproportionately white, and fewer than 2 percent of these clinical trials focused on minorities specifically. Special correspondent Cat Wise reports on the problem and efforts to correct it.
The full episode is no longer available for online streaming. Why?
Please continue to enjoy extra(s) from this episode.
Problems Playing Video? | Closed Captioning